When omalizumab is effective, should treatment be for life?

M. Sanchez-Carpintero Abad (Madrid, Spain), V. Collados Arroyo (Madrid, Spain), G. Doblaré Higueras (Madrid, Spain), A. Henriquez Santana (Madrid, Spain), F. Ruiz Hornillos (Madrid, Spain), S. Blanco Bermejo (Madrid, Spain), F. Roig Vazquez (Madrid, Spain)

Source: International Congress 2018 – Asthma management
Session: Asthma management
Session type: Poster Discussion
Number: 1697
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-posterWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Sanchez-Carpintero Abad (Madrid, Spain), V. Collados Arroyo (Madrid, Spain), G. Doblaré Higueras (Madrid, Spain), A. Henriquez Santana (Madrid, Spain), F. Ruiz Hornillos (Madrid, Spain), S. Blanco Bermejo (Madrid, Spain), F. Roig Vazquez (Madrid, Spain). When omalizumab is effective, should treatment be for life?. 1697

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: